Mariner
CRVO icon

Mariner’s CervoMed CRVO Stock Holding History

Mariner’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,937
Closed -$30.3K – 3471
2024
Q4 		$30.3K Buy
+12,937
New +$126K ﹤0.01% 3330

Other funds holding CRVO

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
AAS
Avantax Advisory Services Dallas, Texas $18.2B AUM 15.06% 1-Year Est. Return

Mariner's CRVO Position: Q1 2025 in Review

Mariner sold out of CervoMed (CRVO) in Q1 2025, closing a stake of 12,937 shares — an estimated $30.3K sold.

Mariner first reported a position in CRVO in Q4 2024 and held it in 1 quarter. The position peaked at $30.3K in Q4 2024. 48 funds tracked by Wall St. Rank hold CRVO as of Q1 2025.

  • Mariner reported no remaining CervoMed position as of Q1 2025 after selling out during the quarter.
  • Mariner sold 12,937 CervoMed shares in Q1 2025, an estimated $30.3K.
  • Mariner first reported a position in CervoMed in Q4 2024 and held it in 1 quarter.
  • Mariner's CervoMed position peaked at $30.3K in Q4 2024.
  • 48 funds tracked by Wall St. Rank held CervoMed as of Q1 2025.

Based on Mariner's 13F filing for Q1 2025, filed 15 May 2025.